Clinical trial
The Avastin vs Visudyne for Neovascular AMD Study
NCT00390026 · St. Erik Eye Hospital, Other · Withdrawn
Key facts
| NCT number | NCT00390026 |
|---|---|
| Title | The Avastin vs Visudyne for Neovascular AMD Study |
| Official title | A Prospective, Randomized, Double-masked, Controlled Study on Intravitreal Bevacizumab (Avastin) Versus Verteporfin (Visudyne) Photodynamic Therapy (PDT) for Patients With Neovascular Age-related Macular Degeneration (AMD) |
| Lead sponsor | St. Erik Eye Hospital, Other |
| Status | Withdrawn |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Age-related Macular Degeneration |
| Intervention type | Drug |
| Interventions | Bevacizumab (Avastin), Verteporfin photodynamic therapy (PDT) |
| Enrollment | 0 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Oct 19, 2006 |
| Last update posted | Jan 31, 2024 |
| Countries | Sweden |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: